Financial Statement 280-

Ethics Simulation Game

Barbara Spencer

University of Phoenix

A Company Ethics Profiled

Group: PA100S009

Dr. Richard Arvizu

May16, 2011

,

The issue is G- BioSport sells health care enhancemen, G-BioSport was not required to meet prior approval from the Federal drug Administration before they put their product on the market. After G-BioSport ran test, it was determined that there were traces of Contaminant in the sample that was received.   The quality control manager must identify the development solutions to save the company, and identify the problems  The question at hand is to warn and give the consumers information to provide them about the contaminant.

I first addressed the contaminate products, and also I have decided to provide the consumers with information on the increased risk to allow them to make informed choices.   Consumers have the right to know about the risk that they’re taking.  We have to remind ourselves that the consumers keep us in business by purchasing our products.   We will not sell products that don’t meet U.S. safety requirements in a foreign market with lower safety restrictions. For now on, I’ll apply all U.S. safety standards or none at all.  All Consumers have the right to know about the safety standards for each product that meets its stated purpose. and the right to have industry wide safety standards to be based on input from members of the industry.

The first decision that had to be made was about a product already on the market that was contaminated, yet only put a small percentage of users at a low risk.   After narrowing the possibilities down to two solutions, the choice was made to warn customers of the potential dangers but to continue selling. Originally, this scenario had a familiar ring and the Ford Pinto case came into mind. (DeGeorge,...